Biotech Values

[DewDiligence]

MON reported strong results for the fiscal quarter ending 5/31/11 and raised FY2011 EPS guidance:

#msg-64830755

After a problem-laden FY2010, things are definitely looking brighter for MON, and the stock was up 10% this week. I’ve posted ad nauseam about why I consider MON one of the premiere plays on The Global Demographic Tailwind, so I won’t repeat those arguments here.